STAT3 and leukemia: Further work in this area is warranted because compounds can have many clinical applications in addition to cancer therapy: Effects of STAT3 ablation in natural killer (NK) cells suggested that STAT3 inhibitors can be used to stimulate cytolytic activity of NK cells against leukemia (27).